The Economic Times is tracking live trading activity in shares of Cipla Ltd, the Indian pharmaceutical company, in its stock liveblog for September 8, 2026.

Cipla is one of India's largest pharmaceutical companies, with a business spanning respiratory, cardiology, anti-infectives, and urology therapies as well as a global footprint across markets such as India, North America, South Africa, and other emerging economies. The stock is listed on Indian exchanges and is a constituent of the Nifty 50 benchmark index, making its intraday moves a routine focus for market watchers.

The live coverage follows a range of standard market metrics for the stock, including bonus and dividend updates, the company's financial snapshot, its current market position and market price, and its price movement during the trading session.

According to the live updates, Cipla's share price has moved past its 100-day simple moving average, a technical indicator that reflects the average closing price of the stock over the past 100 trading sessions. Traders commonly track such moving averages as reference levels: a price trading above a medium-term average like the 100-day line is often read by technical analysts as a shift in near-term momentum, while positions below it are viewed the opposite way. The indicator is a descriptive measure of recent price trends rather than a forecast of future performance.

Readers can follow the ongoing updates on The Economic Times stock liveblog: Cipla Share Price Live Updates.